SCHEMBL5944513

SCHEMBL5944513

C[N+]1(c2ccccc2)CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 5/20 0.40
APOBEC3G Q9HC16 5/20 0.40
PABPC1 P11940 2/20 0.40
EIF4H Q15056 1/20 0.40
CHRM2 P08172 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
CHRNA4 P43681 3/20 0.35
CYP3A4 P08684 2/20 0.35
CHRNB2 P17787 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA7 P36544 2/20 0.35
ALOX15 P16050 1/20 0.35
NFKB1 P19838 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5281905 0.97 APOBEC3A (0.37) APOBEC3AAPOBEC3GPABPC1EIF4HCHRM2
Cyanamide SCHEMBL15435940 0.85 CHRM2 (0.32) APOBEC3AAPOBEC3GPABPC1EIF4HCHRM2
SCHEMBL15435941 0.82 CHRM2 (0.30) APOBEC3AAPOBEC3GPABPC1EIF4HCHRM2
SCHEMBL16612447 0.79 KMT2A (0.44) APOBEC3AAPOBEC3GPABPC1EIF4HCHRM2
SCHEMBL16612732 0.79 KMT2A (0.44) APOBEC3AAPOBEC3GPABPC1EIF4HCHRM2
SCHEMBL5944497 0.78 POLB (0.42) APOBEC3AAPOBEC3GKMT2AALDH1A1CYP3A4
SCHEMBL9481163 0.76 CHKA (0.32) CHRM5ALDH1A1CYP3A4LMNAMAPT
SCHEMBL15293601 0.76 CYP1A2 (0.43) APOBEC3AAPOBEC3GCHRM2CHRM1CHRM3
SCHEMBL9064783 0.76 ACHE (0.42) ALDH1A1HPGDCHRNA7MAPK1POLB
SCHEMBL16612635 0.75 KMT2A (0.38) APOBEC3AAPOBEC3GPABPC1EIF4HCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112180705-B Electrophotographic belt and electrophotographic image forming apparatus 佳能株式会社 2024-06-14 CN disclosed
US-11813883-B2 Electrophotographic member and electrophotographic image forming apparatus CANON KABUSHIKI KAISHA (JP) 2023-11-14 US disclosed
US-9091926-B2 Method of making planographic printing plate and planographic printing plate FUJIFILM CORPORATION (JP) 2015-07-28 US disclosed
US-8993216-B2 Method of producing a planographic printing plate FUJIFILM CORPORATION (JP) 2015-03-31 US disclosed
US-20130260317-A1 METHOD OF PRODUCING A PLANOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2013-10-03 US disclosed
US-20130255516-A1 METHOD OF MAKING PLANOGRAPHIC PRINTING PLATE AND PLANOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2013-10-03 US disclosed
US-20070129576-A1 Process for preparing fluorine-containing norbornene derivative DAIKIN INDUSTRIES, LTD. 2007-06-07 US disclosed
US-7186773-B2 Process for preparing fluorine-containing norbornene derivative DAIKIN INDUSTRIES, LTD. (JP) 2007-03-06 US disclosed
US-20070020479-A1 Luminescent-polymer composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-01-25 US disclosed
US-20070020479-A1 Luminescent-polymer composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-01-25 US disclosed
US-20060186419-A1 Light-emitting device KABUSHIKI KAISHA TOSHIBA (JP) 2006-08-24 US disclosed
US-5202042-A Carboxylic acid salt of cationic nitrogen-containing heterocyclic compound in aprotic solvent or solvent mixture containing polyol NIPPON CHEMI-CON CORPORATION (JP) 1993-04-13 US disclosed
EP-0281994-A1 An electrolyte for electrolytic capacitor NIPPON CHEMI-CON CORPORATION (JP) 1988-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129576-A1 Process for preparing fluorine-containing norbornene derivative ADH1A, FLNA, FFAR2 APOBEC3A 1350/4885APOBEC3G 2255/4885PABPC1 3948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.